Certified by Founder
Lodge
Arpeggio Biosciences
start up
United States
- Boulder, CO
- 08/09/2022
- Series A
- $17,000,000
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
- Industry Biotechnology Research
- Website https://www.arpeggiobio.com/
- LinkedIn https://www.linkedin.com/company/arpeggio-biosciences/
Related People
Joey AzofeifaFounder
United States -
Boulder, Colorado
I work with biologists, mathematicians and computer scientists to build technology that will better our understanding of human disease.
SavvyMoney | $225,000,000 | (Oct 28, 2025)
WorkHero | $5,000,000 | (Oct 28, 2025)
Honey Health | $7,800,000 | (Oct 28, 2025)
Paygentic | $2,000,000 | (Oct 28, 2025)
Natural | $9,800,000 | (Oct 28, 2025)
PodPlay Technologies | $8,000,000 | (Oct 28, 2025)
Seneca | $60,000,000 | (Oct 28, 2025)
Serval | $47,000,000 | (Oct 28, 2025)
Bridge(US) | $5,100,000 | (Oct 28, 2025)
Vermeer | $10,000,000 | (Oct 24, 2025)
Apriority Financial, Inc. | $2,300,000 | (Oct 24, 2025)
GradBridge | $20,000,000 | (Oct 24, 2025)